Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov 15:11:e16149.
doi: 10.7717/peerj.16149. eCollection 2023.

Pharmacokinetic and pharmacodynamic herb-drug interactions-part I. Herbal medicines of the central nervous system

Szilvia Czigle  1 , Milan Nagy  1 , Přemysl Mladěnka  2 , Jaroslav Tóth  1 ; OEMONOM.
Affiliations
Review

Pharmacokinetic and pharmacodynamic herb-drug interactions-part I. Herbal medicines of the central nervous system

Szilvia Czigle et al. PeerJ. .

Abstract

Unlike conventional drug substances, herbal medicines are composed of a complex of biologically active compounds. Therefore, the potential occurrence of herb-drug interactions is even more probable than for drug-drug interactions. Interactions can occur on both the pharmacokinetic and pharmacodynamic level. Herbal medicines may affect the resulting efficacy of the concomitantly used (synthetic) drugs, mainly on the pharmacokinetic level, by changing their absorption, distribution, metabolism, and excretion. Studies on the pharmacodynamic interactions of herbal medicines and conventional drugs are still very limited. This interaction level is related to the mechanism of action of different plant constituents. Herb-drug interactions can cause changes in drug levels and activities and lead to therapeutic failure and/or side effects (sometimes toxicities, even fatal). This review aims to provide a summary of recent information on the potential drug interactions involving commonly used herbal medicines that affect the central nervous system (Camellia, Valeriana, Ginkgo, Hypericum, Humulus, Cannabis) and conventional drugs. The survey databases were used to identify primary scientific publications, case reports, and secondary databases on interactions were used later on as well. Search keywords were based on plant names (botanical genera), officinal herbal drugs, herbal drug preparations, herbal drug extracts.

Keywords: Camellia; Cannabis; Ginkgo; Herbal medicine-drug interaction; Humulus; Hypericum; Pharmacodynamic; Pharmacokinetic; Review; Valeriana.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Abourashed EA, Koetter U, Brattström A. In vitro binding experiments with a Valerian, hops and their fixed combination extract (Ze91019) to selected central nervous system receptors. Phytomedicine. 2004;11(7–8):633–638. doi: 10.1016/j.phymed.2004.03.005. - DOI - PubMed
    1. Ahlemeyer B, Krieglstein J. Neuroprotective effects of Ginkgo biloba extract. Cellular and Molecular Life Sciences. 2003;60(9):1779–1792. doi: 10.1007/s00018-003-3080-1. - DOI - PMC - PubMed
    1. Alberti TB, Barbosa WL, Vieira JL, Raposo NR, Dutra RC. (-)-β-Caryophyllene, a CB2 receptor-selective phytocannabinoid, suppresses motor paralysis and neuroinflammation in a murine model of multiple sclerosis. International Journal of Molecular Sciences. 2017;18(4):691. doi: 10.3390/ijms18040691. - DOI - PMC - PubMed
    1. Ali Y, Shams T, Wang K, Cheng Z, Li Y, Shu W, Bao X, Zhu L, Murray M, Zhou F. The involvement of human organic anion transporting polypeptides (OATPs) in drug-herb/food interactions. Chinese Medicine. 2020;15(1):71. doi: 10.1186/s13020-020-00351-9. - DOI - PMC - PubMed
    1. Alscher DM, Klotz U. Drug interaction of herbal tea containing St. John’s wort with cyclosporine. Transplant International. 2003;16(7):543–544. doi: 10.1007/s00147-003-0560-z. - DOI - PubMed

MeSH terms

LinkOut - more resources